Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
Sifan Chen, Ayana L. Henderson, Michael C. Petriello, et al.
Cell Metabolism (2019) Vol. 30, Iss. 6, pp. 1141-1151.e5
Open Access | Times Cited: 305

Showing 26-50 of 305 citing articles:

Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development
Carolina Simó, Virginia García‐Cañas
Food & Function (2020) Vol. 11, Iss. 8, pp. 6745-6776
Open Access | Times Cited: 83
ER Stress-Sensor Proteins and ER-Mitochondrial Crosstalk—Signaling Beyond (ER) Stress Response
Vaishali Kumar, Shuvadeep Maity
Biomolecules (2021) Vol. 11, Iss. 2, pp. 173-173
Open Access | Times Cited: 82
Gut Metabolite TMAO Induces Synaptic Plasticity Deficits by Promoting Endoplasmic Reticulum Stress
Manoj Govindarajulu, Priyanka D. Pinky, Ian Steinke, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 78
Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease
Qing Fang, Binjie Zheng, Na Liu, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 75
Intestinal microbial metabolites in human metabolism and type 2 diabetes
Hilde Herrema, Jan Hendrik Niess
Diabetologia (2020) Vol. 63, Iss. 12, pp. 2533-2547
Open Access | Times Cited: 73
Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis
Marco Witkowski, Mario Witkowski, Julian Friebel, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 10, pp. 2367-2384
Open Access | Times Cited: 73
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
Leilei Du, Qi Li, Huan Yi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112839-112839
Open Access | Times Cited: 70
Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways
Fatma Saaoud, Lu Liu, Keman Xu, et al.
JCI Insight (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 67
Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
BingYu Wang, Jun Qiu, JiangFang Lian, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 65
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 57
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
Yuwei Wang, Jin Zhao, Yunlong Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Zixin Ye, Chen Lulu, Xiangchang Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 48
Gut microbe-targeted choline trimethylamine lyase inhibition improves obesity via rewiring of host circadian rhythms
Rebecca C. Schugar, Christy M. Gliniak, Lucas J. Osborn, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 42
Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study
Meng Wang, Zeneng Wang, Yujin Lee, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2022) Vol. 42, Iss. 9
Open Access | Times Cited: 42
Local and systemic effects of microbiome‐derived metabolites
Igor Spivak, Leviel Fluhr, Eran Elinav
EMBO Reports (2022) Vol. 23, Iss. 10
Open Access | Times Cited: 42
Blood–brain barrier and gut barrier dysfunction in chronic kidney disease with a focus on circulating biomarkers and tight junction proteins
Leah Hernandez, Liam J. Ward, Samsul Arefin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice
Robert N. Helsley, Tatsunori Miyata, Anagha Kadam, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 41
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease
Ahmad Al Samarraie, Maxime Pichette, Guy Rousseau
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5420-5420
Open Access | Times Cited: 40
The triangular relationship between traditional Chinese medicines, intestinal flora, and colorectal cancer
Yuqing Zou, Shuling Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 539-567
Closed Access | Times Cited: 40
Implications of trimethylamine N-oxide (TMAO) and Betaine in Human Health: Beyond Being Osmoprotective Compounds
Ashal Ilyas, Yasanandana Supunsiri Wijayasinghe, Ilyas Khan, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 39
Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis
Meng Wang, Xinmin S. Li, Zeneng Wang, et al.
European Heart Journal (2023) Vol. 44, Iss. 18, pp. 1608-1618
Closed Access | Times Cited: 37
Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
Albert Stec, Mariusz Sikora, Magdalena Maciejewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3494-3494
Open Access | Times Cited: 34
The gut microbiota‐astrocyte axis: Implications for type 2 diabetic cognitive dysfunction
Zi-han Li, Yayi Jiang, Caiyi Long, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. S1, pp. 59-73
Open Access | Times Cited: 28
Impacts of maternal microbiota and microbial metabolites on fetal intestine, brain, and placenta
Aleksi Husso, Tiina Pessa‐Morikawa, Ville Koistinen, et al.
BMC Biology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 28
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Rong Cao, Huimin Tian, Yu Zhang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 27

Scroll to top